Europe - FRA:H6D0 - GB00BMX86B70 - Common Stock
Taking everything into account, H6D0 scores 3 out of 10 in our fundamental rating. H6D0 was compared to 49 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of H6D0 while its profitability can be described as average. H6D0 is valued correctly, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.2% | ||
ROE | 8.92% | ||
ROIC | 6.11% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 21.31% | ||
PM (TTM) | 12.84% | ||
GM | 60.75% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.53 | ||
Debt/FCF | 5.11 | ||
Altman-Z | 1.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.98 | ||
Quick Ratio | 0.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.67 | ||
Fwd PE | 17.32 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 8.08 | ||
EV/EBITDA | 8.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.87% |
FRA:H6D0 (9/15/2025, 7:00:00 PM)
4.131
-0.07 (-1.62%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 1.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 19.67 | ||
Fwd PE | 17.32 | ||
P/S | 1.43 | ||
P/FCF | 8.08 | ||
P/OCF | 6.96 | ||
P/B | 0.99 | ||
P/tB | N/A | ||
EV/EBITDA | 8.89 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 4.2% | ||
ROE | 8.92% | ||
ROCE | 8.4% | ||
ROIC | 6.11% | ||
ROICexc | 6.63% | ||
ROICexgc | 4145.85% | ||
OM | 21.31% | ||
PM (TTM) | 12.84% | ||
GM | 60.75% | ||
FCFM | 17.65% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.53 | ||
Debt/FCF | 5.11 | ||
Debt/EBITDA | 3.18 | ||
Cap/Depr | 98.15% | ||
Cap/Sales | 2.83% | ||
Interest Coverage | 6.65 | ||
Cash Conversion | 84.66% | ||
Profit Quality | 137.52% | ||
Current Ratio | 0.98 | ||
Quick Ratio | 0.78 | ||
Altman-Z | 1.75 |